NSETrading Window5d ago
Ennature Bio Pharma Limited
Trading Window
Ennature Bio Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
NSEPress Release▲ PositiveExpansion5d ago
Ennature Bio Pharma Limited
Press Release
Ennature Bio Pharma Limited listed on NSE and BSE on 4 November 2026, with a revenue of Rs 246 crore in FY26, driven by branded nutraceuticals. The company has three complementary businesses: plant-based pharmaceutical ingredients, biopolymers, and nutraceuticals.